Osilodrostat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Osilodrostat. Educational only — not medical advice.
Labeled uses
ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.
Source: FDA labeling via NIH DailyMed (set f3a5ec24…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.